20% With Cancer on Checkpoint Inhibitors Get Thyroid Dysfunction 20% With Cancer on Checkpoint Inhibitors Get Thyroid Dysfunction

Proportion is far higher than those found in clinical trials of the cancer drugs; study finds differences by cancer type.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news